We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.9B
AUM Growth
+$1.63B
Cap. Flow
-$1.42B
Cap. Flow %
-4.19%
Top 10 Hldgs %
15.42%
Holding
3,077
New
93
Increased
384
Reduced
2,402
Closed
59

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$41.6M
2
XOM icon
ExxonMobil
XOM
+$33.5M
3
DELL
DELL INC
DELL
+$27.8M
4
GE icon
GE Aerospace
GE
+$22.8M
5
IBM icon
IBM
IBM
+$19M

Sector Composition

Rank Sector Weight
1 Financials 15.28%
2 Technology 13.93%
3 Healthcare 12.71%
4 Industrials 11.47%
5 Energy 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INWK
2451
DELISTED
InnerWorkings, Inc.
INWK
$365K ﹤0.01%
46,805
TRK
2452
DELISTED
Speedway Motorsports, Inc.
TRK
$365K ﹤0.01%
18,388
-1,000
-5% -$19.1K
CALX icon
2453
Calix
CALX
$2.49B
$364K ﹤0.01%
37,717
-500
-1% -$5.35K
LMOS
2454
DELISTED
Lumos Networks Corp
LMOS
$364K ﹤0.01%
17,321
+350
+2% +$7.72K
CLB icon
2455
Core Laboratories
CLB
$515M
$363K ﹤0.01%
1,900
+200
+12% +$37.2K
TPH
2456
DELISTED
Tri Pointe Homes
TPH
$363K ﹤0.01%
18,210
-1,400
-7% -$24K
CHFN
2457
DELISTED
Charter Financial Corp
CHFN
$363K ﹤0.01%
33,707
-2,000
-6% -$21.6K
DVAX
2458
DELISTED
Dynavax Technologies
DVAX
$362K ﹤0.01%
18,493
+800
+5% +$11.7K
PACB icon
2459
Pacific Biosciences
PACB
$447M
$361K ﹤0.01%
69,114
-2,400
-3% -$11K
GNMK
2460
DELISTED
GenMark Diagnostics, Inc
GNMK
$361K ﹤0.01%
27,112
+1,300
+5% +$15.8K
RSH
2461
DELISTED
RADIOSHACK CORP
RSH
$361K ﹤0.01%
138,826
-8,800
-6% -$25.6K
PWOD
2462
DELISTED
Penns Woods Bancorp
PWOD
$360K ﹤0.01%
10,578
-225
-2% -$7.56K
MCBI
2463
DELISTED
METROCORP BANCSHARES INC
MCBI
$360K ﹤0.01%
23,879
-1,400
-6% -$20K
FRPH icon
2464
FRP Holdings
FRPH
$431M
$359K ﹤0.01%
17,298
-1,200
-6% -$22.7K
PETS icon
2465
PetMed Express
PETS
$42.5M
$359K ﹤0.01%
21,572
-100
-0.5% -$1.56K
AUD
2466
DELISTED
Audacy, Inc.
AUD
$359K ﹤0.01%
34,178
-2,100
-6% -$19.9K
RPRX
2467
DELISTED
Repros Therapeutics Inc.
RPRX
$359K ﹤0.01%
19,641
+1,400
+8% +$26.4K
BBBY
2468
Bed Bath & Beyond
BBBY
$530M
$358K ﹤0.01%
15,462
-133
-0.9% -$2.69K
KEM
2469
DELISTED
KEMET Corporation
KEM
$358K ﹤0.01%
63,462
-4,000
-6% -$22.1K
GHM icon
2470
Graham Corp
GHM
$1.23B
$357K ﹤0.01%
9,848
TXMD icon
2471
TherapeuticsMD
TXMD
$23.6M
$357K ﹤0.01%
1,370
+14
+1% +$3.07K
ACLS icon
2472
Axcelis
ACLS
$4.29B
$356K ﹤0.01%
36,496
-2,475
-6% -$22.5K
DXLG icon
2473
Destination XL Group
DXLG
$31.4M
$356K ﹤0.01%
54,136
-3,700
-6% -$24.4K
MFIN icon
2474
Medallion Financial
MFIN
$251M
$356K ﹤0.01%
24,828
-400
-2% -$6.25K
SHYF
2475
DELISTED
The Shyft Group
SHYF
$356K ﹤0.01%
53,147
-3,100
-6% -$20.3K

Similar funds

RhumbLine Advisers's Q4 2013 Portfolio in Review

As of Q4 2013, RhumbLine Advisers held 3,077 positions worth $33.9B, up 5% from $32.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.42B in Q4 2013, closing 59 positions and reducing 2,402 holdings. Its most notable exit was NYSE EURONEXT INC, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Transocean worth $12.5M.

  • RhumbLine Advisers's largest Q4 2013 buy was Transocean: 252,714 shares worth $12.5M.
  • RhumbLine Advisers added most to Meta Platforms (Facebook) in Q4 2013, an estimated $50.1M increase.
  • RhumbLine Advisers's biggest Q4 2013 reduction was Apple, cutting an estimated $41.6M.
  • RhumbLine Advisers fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $15.2M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.9B portfolio in Q4 2013.
  • RhumbLine Advisers opened 93 new positions and closed 59 in Q4 2013.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $33.9B.

Based on RhumbLine Advisers's 13F filing for Q4 2013, filed 3 Feb 2014.